108 related articles for article (PubMed ID: 15506053)
1. [Botulinum toxin in Austria and neighboring countries].
Homann CN; Kriechbaum N; Suppan K; Wenzel K; Crevenna R; Feichtinger M; Ivanic G
Wien Klin Wochenschr; 2001; 113 Suppl 4():45-7. PubMed ID: 15506053
[No Abstract] [Full Text] [Related]
2. [Reimbursement strategies for botulinum toxin type A in Austria].
Diez J; Endel G
Wien Klin Wochenschr; 2001; 113 Suppl 4():42-4. PubMed ID: 15506052
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A for the treatment of headache: pro.
Blumenfeld A
Headache; 2004 Sep; 44(8):825-30. PubMed ID: 15330834
[No Abstract] [Full Text] [Related]
4. [Botulinum toxin treatment -- state of the art 2000].
Auff E; Poewe W; Schnider P; Wissel J
Wien Klin Wochenschr; 2001; 113 Suppl 4():1. PubMed ID: 15506043
[No Abstract] [Full Text] [Related]
5. Financial benefits the real motivator behind Botox.
Schubert D
CDS Rev; 2009; 102(2):6. PubMed ID: 19415848
[No Abstract] [Full Text] [Related]
6. The botox boom.
Noonan D; Adler J
Newsweek; 2002 May; 139(19):50-6, 58. PubMed ID: 12037916
[No Abstract] [Full Text] [Related]
7. Health economics and intradetrusor injections of botulinum for the treatment of detrusor overactivity.
Sangster P; Kalsi V
BJU Int; 2008 Jul; 102 Suppl 1():17-9. PubMed ID: 18665974
[TBL] [Abstract][Full Text] [Related]
8. Cosmetic use of botulinum toxin.
Med Lett Drugs Ther; 1999 Jul; 41(1057):63-4. PubMed ID: 10436771
[No Abstract] [Full Text] [Related]
9. Cost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence.
Siddiqui NY; Amundsen CL; Visco AG; Myers ER; Wu JM
J Urol; 2009 Dec; 182(6):2799-804. PubMed ID: 19837427
[TBL] [Abstract][Full Text] [Related]
10. Beyond Botox.
Kher U
Time; 2003 May; 161(20):58-9. PubMed ID: 12776449
[No Abstract] [Full Text] [Related]
11. Botulinum toxin type A for the treatment of headache: con.
Welch KM
Headache; 2004 Sep; 44(8):831-3. PubMed ID: 15330835
[No Abstract] [Full Text] [Related]
12. The use of botulinum toxin A in perioral rejuvenation.
Kaplan SE; Sherris DA; Gassner HG; Friedman O
Facial Plast Surg Clin North Am; 2007 Nov; 15(4):415-21, v-vi. PubMed ID: 18005882
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin in primary care medicine.
Felber ES
J Am Osteopath Assoc; 2006 Oct; 106(10):609-14. PubMed ID: 17122031
[TBL] [Abstract][Full Text] [Related]
14. Worldwide experience with botulinum toxin type A.
Karsenti G
J Cosmet Laser Ther; 2003 Dec; 5(3-4):208-9. PubMed ID: 14741833
[No Abstract] [Full Text] [Related]
15. The place of botulinum toxin type A in the treatment of focal hyperhidrosis.
Benohanian A
Br J Dermatol; 2005 Aug; 153(2):460-1; author reply 461. PubMed ID: 16086777
[No Abstract] [Full Text] [Related]
16. Differences in botulinum toxins: time to end the confusion.
Brin MF; Tan K; Gallagher C
J Cosmet Laser Ther; 2009 Sep; 11(3):180-1. PubMed ID: 19626521
[No Abstract] [Full Text] [Related]
17. Botulinum toxin in the treatment of strabismus. A review of its use and effects.
Kowal L; Wong E; Yahalom C
Disabil Rehabil; 2007 Dec; 29(23):1823-31. PubMed ID: 18033607
[TBL] [Abstract][Full Text] [Related]
18. [Applications of botulinum toxin in ophthalmology].
Lanzl I; Merté RL; Roggenkämper P
Klin Monbl Augenheilkd; 2009 Jan; 226(1):R1-8; quiz R9-12. PubMed ID: 19173157
[No Abstract] [Full Text] [Related]
19. Botulinum toxin and cerebral palsy: time for reflection?
Kerr Graham H; Rodda JM
Dev Med Child Neurol; 2006 May; 48(5):399. PubMed ID: 16608552
[No Abstract] [Full Text] [Related]
20. Botulinum toxin: from life-threatening disease to novel medical therapy.
Mahajan ST; Brubaker L
Am J Obstet Gynecol; 2007 Jan; 196(1):7-15. PubMed ID: 17240220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
